Evaluation of Inflammatory Markers in Pregnant Women at Risk, for the Prediction of Preeclampsia

1. Catarino C, Santos-Silva A, Belo L, et al. Inflammatory Disturbances in Preeclampsia: Relationship between Maternal and Umbilical Cord Blood. J Pregnancy. 2012;2012: Article ID 684384.10.1155/2012/684384336623922685662Search in Google Scholar

2. Xiao JP, Yin YX, Gao YF, et al. The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia. Cytokine 2012;60:856-860.10.1016/j.cyto.2012.07.03922921280Search in Google Scholar

3. Ouyang Y, Li SJ, Zhang Q, Cai H, Chen HP. Interaction Between Inflammatory and Oxidative Stress in Preeclampsia. Hypertens Pregnancy. 2009;28:56-62.10.1080/1064195080223306419165670Search in Google Scholar

4. Guven M, Coskun A, Ertas IE, et al. Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight. Hypertens Pregnancy. 2009;28:190-200.10.1080/1064195080260117919437229Search in Google Scholar

5. Haedersdal S, Salvig J, Aabye M, et al. Inflammatory Markers in the Second Trimester Prior to Clinical Onset of Preeclampsia, Intrauterine Growth Restriction, and Spontaneous Preterm Birth. Inlammation. 2013;4:907-913.10.1007/s10753-013-9619-x23471783Search in Google Scholar

6. Babu MS, Bobby Z, Habeebullah S. Increased inflammatory response and imbalance in blood and urinary oxidant-antioxidant status in South Indian women with gestational hypertension and preeclampsia. Clin Biochem. 2012;45:835-838.10.1016/j.clinbiochem.2012.04.01822561001Search in Google Scholar

7. Mihu D, Sabau L, Costin N, Ciortea R, Malutan A, Mihu MC. Implication of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia. Journal of maternal - Fetal and Neonatal Medicine. 2012;27(7):944-951.10.3109/14767058.2011.60079621740316Search in Google Scholar

8. Kumru S, Godekmerdan A, Kutlu S, Ozcan Z. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2006;124:164-167.10.1016/j.ejogrb.2005.05.00716054746Search in Google Scholar

9. Mihu D, Costin N, Sabau L, et al. Implications of serum C-Reactive Protein in normal pregnancy and preeclampsia. Obstetrica si ginecologia. 2011;LIX(Supl): 60-67.Search in Google Scholar

10. Prins J, Gomez-Lopez N, Robertson SA. Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol. 2012;95:1-14.10.1016/j.jri.2012.05.00422819759Search in Google Scholar

11. Ozler A, Turgut A, Sak ME, et al. Serum levels of tumor necrosis factor - alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci. 2012;16:1707-1712.Search in Google Scholar

12. LeMarca B, Brewer J, Wallace K. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Infereron Cytokine Mediator Res. 2011;3:59-64.Search in Google Scholar

13. Stonek F, Hafner E, Metzenbauer M, et al. Absence of an association of tumor necrosis factor (TNF)-alpha and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. J Reprod Immunol. 2008;77:85-90.10.1016/j.jri.2007.04.00317544514Search in Google Scholar

14. Jonsson Y, Ruber M, Matthiesen L, et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol. 2006;70:83-91.10.1016/j.jri.2005.10.007Search in Google Scholar

15. Luppi P, Tse H, Lain KY, et al. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol. 2006;56:135-144.10.1111/j.1600-0897.2006.00386.xSearch in Google Scholar

16. Freeman DJ, McManus F, Brown F, et al. Short and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension. 2004;44:708-714.10.1161/01.HYP.0000143849.67254.caSearch in Google Scholar

17. Tukacs P, Green KL, Nikaeo A, Kauma SW. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol. 2003;188:740-744.10.1067/mob.2003.134Search in Google Scholar

18. Hayashi M, Ueda Y, Ohkura T, Inaba N. Interleukin-6 concentration in the placenta and blood in normal pregnancies and preeclampsia. Horm. Metab. Res. 2005;37:419-424.Search in Google Scholar

19. Mihu D, Costin N, Sabau L, et al. Interleukina-6 - marker al sindromului inflamator in preeclampsie. Gineco.ro. 2010;22:230-234.Search in Google Scholar

20. Wolf M, Kettyle L, Sandler L, et al. Obesity and preeclampsia: The potential role of inflammation. Obstet Gynecol. 2001;98:757-762.10.1097/00006250-200111000-00009Search in Google Scholar

21. Tjoa ML, van Vugt JM, Go AT, Blankenstein CB, Oudejans CB. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003;59:29-37.10.1016/S0165-0378(02)00085-2Search in Google Scholar

22. Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop preeclampsia. BJOG. 2002;109:297-301.10.1111/j.1471-0528.2002.01130.x11950185Search in Google Scholar

23. Djurovic S, Clausen T, Wergeland R, et al. Absence of systemic inflammatory response at 18 weeks of gestation in women with subsequent preeclampsia. BJOG. 2002;109:759-764.10.1111/j.1471-0528.2002.01330.x12135211Search in Google Scholar